Search Results - "Sabbaghi, MohammadA"

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer by Sabbaghi, MohammadA, Gil-Gómez, Gabriel, Guardia, Cristina, Servitja, Sonia, Arpí, Oriol, García-Alonso, Sara, Menendez, Silvia, Arumi-Uria, Montserrat, Serrano, Laia, Salido, Marta, Muntasell, Aura, Martínez-García, Maria, Zazo, Sandra, Chamizo, Cristina, González-Alonso, Paula, Madoz-Gúrpide, Juan, Eroles, Pilar, Arribas, Joaquin, Tusquets, Ignasi, Lluch, Ana, Pandiella, Atanasio, Rojo, Federico, Rovira, Ana, Albanell, Joan

“…Trastuzumab-emtansine (T-DM1) is a standard treatment in advanced HER2-positive breast cancer. However, resistance inevitably occurs. We aimed to identify…”
Get full text

Targeted metabolomics in formalin-fixed paraffin-embedded tissue specimens: Liquid chromatography-tandem mass spectrometry determination of acidic metabolites in cancer research by Gomez-Gomez, Alex, Sabbaghi, MohammadA, Haro, Noemí, Albanell, Joan, Menéndez, Silvia, González, Mónica, Gil-Gómez, Gabriel, Rovira, Ana, Pozo, Oscar J.

“…Formalin-fixed paraffin-embedded (FFPE) tissues play an irreplaceable role in cancer research. Although extensive research has been conducted for the detection…”
Get full text

Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer by Guardia, Cristina, Bianchini, Giampaolo, Arpí-LLucià, Oriol, Menendez, Silvia, Casadevall, David, Galbardi, Barbara, Dugo, Matteo, Servitja, Sonia, Montero, Juan Carlos, Soria-Jiménez, Luis, Sabbaghi, MohammadA, Peña, Raul, Madoz-Gúrpide, Juan, Lloveras, Belen, Lluch, Ana, Eroles, Pilar, Arribas, Joaquin, Pandiella, Atanasio, Gianni, Luca, Rojo, Federico, Rovira, Ana, Albanell, Joan

“…To characterize expression of neuregulin-1 (NRG1), an HER3 ligand, in HER2-positive breast cancer and its relation with the efficacy of trastuzumab with or…”
Get full text

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma by Rojo, Federico, González-Pérez, Abel, Furriol, Jessica, Nicolau, Ma Jesús, Ferrer, Jaime, Burgués, Octavio, Sabbaghi, MohammadA, González-Navarrete, Irene, Cristobal, Ion, Serrano, Laia, Zazo, Sandra, Madoz, Juan, Servitja, Sonia, Tusquets, Ignasi, Albanell, Joan, Lluch, Ana, Rovira, Ana, Eroles, Pilar

“…Background: NF- κ B signalling appears deregulated in breast tumours. The purpose of this study was to determine whether the non-canonical NF- κ B pathway, is…”
Get full text

Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer by García-Parra, Jetzabel, Dalmases, Alba, Morancho, Beatriz, Arpí, Oriol, Menendez, Silvia, Sabbaghi, MohammadA, Zazo, Sandra, Chamizo, Cristina, Madoz, Juan, Eroles, Pilar, Servitja, Sonia, Tusquets, Ignasi, Yelamos, Jose, Lluch, Ana, Arribas, Joaquin, Rojo, Federico, Rovira, Ana, Albanell, Joan

“…Abstract Aim Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising results in Breast Cancer (BRCA) deficient breast cancer, but not in…”
Get full text

Non-canonical NF-[kappa]B pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma by Rojo, Federico, González-pérez, Abel, Furriol, Jessica, Nicolau, Ma Jesús, Ferrer, Jaime, Burgués, Octavio, Sabbaghi, Mohammada, González-navarrete, Irene, Cristobal, Ion, Serrano, Laia, Zazo, Sandra, Madoz, Juan, Servitja, Sonia, Tusquets, Ignasi, Albanell, Joan, Lluch, Ana, Rovira, Ana, Eroles, Pilar

“…Background:NF-κB signalling appears deregulated in breast tumours. The purpose of this study was to determine whether the non-canonical NF-κB pathway, is…”
Get full text

Effect of trastuzumab on the antiproliferative effects of PI3K inhibitors in HER2+ breast cancer cells with de novo resistance to trastuzumab by Espin, Estefania, Perez-Fidalgo, Jose Alejandro, Tormo, Eduardo, Pineda, Begona, Cejalvo, Juan Miguel, Sabbaghi, MohammadA, Alonso, Elisa, Rovira, Ana, Rojo, Federico, Albanell, Joan, Bermejo, Begona, Burgues, Octavio, Eroles, Pilar, Lluch, Ana

“…Abstract only…”
Get full text

mTOR inhibition and trastuzumab-emtansine (T-DM1) in HER2-positive breast cancer by Casadevall, David, Hernandez-Prat, Anna, Garc A-Alonso, Sara, Arpi-Llucia, Oriol, Menendez, Silvia, Qin, Mengjuan, Guardia, Cristina, Morancho, Beatriz, Sanchez-Mart N, Francisco Javier, Zazo, Sandra, Gavilan, Elena, Sabbaghi, MohammadA, Eroles, Pilar, Cejalvo, Juan Miguel, Lluch, Ana, Rojo, Federico, Pandiella, Atanasio, Rovira, Ana, Albanell, Joan

“…In patients with trastuzumab-resistant HER2-positive breast cancer, the combination of everolimus (mTORC1 inhibitor) with trastuzumab failed to show a…”
Get full text

IL-17A concentration of seminal plasma and follicular fluid in infertile men and women with various clinical diagnoses by Sabbaghi, MohammadA, Aram, Raheleh, Roustaei, Hessam, Fadavi Islam, Mahla, Daneshvar, Maryam, Castaño, A. Raúl, Haghparast, Alireza

“…Seminal plasma and follicular fluid (FF) cytokine analysis are valuable tools for diagnoses and validation of therapeutic approaches for improving the chance…”
Get full text